Abciximab improves 6-month clinical outcome after rescue coronary angioplasty.

American heart journal

Volumn 143, Issue 2, 2002, Pages 334-341

  Petronio, Anna Sonia ^a   Musumeci, Giuseppe ^a   Limbruno, Ugo ^a   De Carlo, Marco ^a   Baglini, Roberto ^a   Paterni, Giovanni ^a   Grazia Delle Donne, Maria ^a   Caravelli, Paolo ^a   Nardi, Carmela ^a   Mariani, Mario ^a  

^a UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; FIBRINOGEN RECEPTOR; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY;

ARTICLE; BLEEDING; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG ANTAGONISM; FEASIBILITY STUDY; FEMALE; HEART INFARCTION; HEART LEFT VENTRICLE FUNCTION; HUMAN; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SALVAGE THERAPY; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT FAILURE; TREATMENT OUTCOME;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIBODIES, MONOCLONAL; ANTICOAGULANTS; COMBINED MODALITY THERAPY; FEASIBILITY STUDIES; FEMALE; HEMORRHAGE; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROSPECTIVE STUDIES; SALVAGE THERAPY; TREATMENT FAILURE; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

MLCS; MLOWN;

EID: 0036480088     PISSN: None     EISSN: 10976744     Source Type: Journal    
DOI: 10.1067/mhj.2002.119762     Document Type: Article

References (0)